The $96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients

We found this article at:

www.businessinsider.nl/gilead-testing-inhaled-remdesivir-coronavirus-trials-start-in-august-2020-6/